Biotechnology halka açık
[search 0]
Daha fazla
Download the App!
show episodes
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
  continue reading
 
Loading …
show series
 
The intersection of healthcare and technology paves the way for revolutionary patient care, shaping the future with precision and personalization. Today, the spotlights are on how getting data ready for AI applications is changing the game in healthcare. I'm thrilled to welcome Christopher J Kouzios, the Principal Owner of Kooz Technologies, an exp…
  continue reading
 
How do we navigate the complexities of workforce management in the era of artificial intelligence? Today's discussion sheds light on the intricacies of HR policies as they adapt to the technological advancements in AI. I’m joined by Bill Pierce, Chief Information Officer at BioIVT, a visionary in leveraging technology to enhance business processes.…
  continue reading
 
The impact of AI on data management, particularly in the realm of biotechnology, is undeniable. It has fundamentally transformed how we approach and utilize vast amounts of data in this field. Joining me is Elisabeth Schwartz, the IT Head at Phathom, to explore the crucial task of preparing data for AI applications and the hurdles we face in ensuri…
  continue reading
 
Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking lucrative opportunities in the pharmaceutical industry, these reports offer invaluable…SourceDrugPatentWatch tarafından oluşturuldu
  continue reading
 
The convergence of technology and business savvy is reshaping the biotech landscape. Today's leaders are adept at harnessing IT to drive profitability and impact lives, turning data and innovation into strategic gold. In this episode, I sit down with Eduard De Vries, a visionary at the intersection of IT and healthcare business strategy. Eduard sha…
  continue reading
 
A revolution in biotechnology is underway, with artificial intelligence at its core, but the fervor over AI adoption brings with it pressing concerns about data protection that cannot be overlooked. In this episode, I'm joined by Bob McCowan, Chief Information Officer at Regeneron, to navigate the crossroads of AI development and data security. We …
  continue reading
 
Automation has become a pivotal force in the advancement of the biotech sector, ushering in a new era of AI-driven solutions. In this episode, I'm joined by David Williamson, the CIO at Abzena and a trailblazer in biotech innovation. We're peeling back the layers of AI integration, from commercial chatbots that defy the conventional, to AI's grip o…
  continue reading
 
Professor Glenn Cohen, Faculty Director of the Petrie-Flom Center at Harvard Law School interviews Dr. Rochelle Walensky, 19th Director of the Centers for Disease Control and Prevention and Senior Academic Fellow at the Petrie-Flom Center. They discuss Dr. Walensky’s career as an infectious disease clinician focused on HIV/AIDS, her experience lead…
  continue reading
 
The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the…SourceDrugPatentWatch tarafından oluşturuldu
  continue reading
 
Welcome to the first episode of the Biotech Bytes podcast! Today, we have an insightful conversation with Bill Wallace from Intercept Pharmaceuticals, exploring the transformative role of AI in the pharmaceutical and biotech industries. Bill talks about how working together and keeping data safe are key in these industries. He dives into the specif…
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical ind…
  continue reading
 
Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical…SourceDrugPatentWatch tarafından oluşturuldu
  continue reading
 
DrugPatentWatch has published a list of research papers citing DrugPatentWatch at https://www.drugpatentwatch.com/citations/ DrugPatentWatch.com is your key to unlocking the world of pharmaceutical research. These primary literature citations can benefit researchers,…SourceDrugPatentWatch tarafından oluşturuldu
  continue reading
 
Should Social Robots be Used to Provide Emotional Support? PARO is a cuddly baby seal used as an emotional companion robot in elder care. Emotional companion robots provide some of the benefits of therapy animals, without the attendant challenges of a live animal. But while emotional companion robots can provide comfort to older adults, they might …
  continue reading
 
How Should We Regulate Digital Health Technology? The current digital health marketplace has been described as a wild west. Every day, consumer products making strong claims are brought to market without sufficient evidence and often withdrawn only when enforcement actions are brought against them. There are already apps that claim to detect melano…
  continue reading
 
How AI Bias Is Affecting Health Care—And What We Can Do About It People are biased, and people build AI, so AI are biased, too. When AI is used in hospitals to treat patients, that bias comes to health care. For example, a 2019 paper in Science found that a commercial risk-prediction tool was less likely to refer equally sick Black people than whit…
  continue reading
 
How secure is data collected by digital pills? Ingestible electronic sensors (IESs or “digital pills”) can be taken with or as a part of a drug in order to collect and record patient data, such as medication adherence or physiological metrics. This information can then be shared with relevant parties, including the patient, family members, and heal…
  continue reading
 
Who Is Liable When AI Injures a Patient? Medical errors happen; doctors are only human. And when doctors make mistakes, the law pertaining to who is liable is usually clear-cut. But what happens if the mistake was made by an AI, included one embedded in a device or a robot? This episode will explore who is liable. Is it the hospital? The developer …
  continue reading
 
Do You Own Your Personal Health Data? Every time you visit the doctor, heaps of personal health data are stored in electronic medical records, a mainstay of the modern health care industry. The rise of big data in healthcare comes with risks, however. Health data is now being sold to external companies and researchers. So, can you own your personal…
  continue reading
 
Should We Tell Patients When AI is Being Used in Their Care? Increasingly, AI is being used in hospitals without patients’ knowledge of its use in their care, let alone their consent. For example, AI is being used to predict the likelihood that a cancer patient will die within the next six months. Hospitals and clinicians are deploying this technol…
  continue reading
 
A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics have revolutionized healthcare by providing effective treatments for complex diseases…SourceDrugPatentWatch tarafından oluşturuldu
  continue reading
 
A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020. The study…SourceDrugPatentWatch tarafından oluşturuldu
  continue reading
 
Loading …

Hızlı referans rehberi